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It is well known that the brain contains large amount of lipids compared with other 
tisues. However, their physiological m回 ningshad been left almost unknown untill recentlv. 
During the last ten y田 rs,various informations on cerebral lipids have been accumulated 
and it has become clear that they act not only as an inert structural constituent but they 
intimately concern with the functional mechanism1l2J了間i3BJ 39J 40J 1oi 11i 12i 13) l01J 101J of the 
nervous system. 
It is often observed that brain swelling or edema which o仁じur出 secondarilyto various 
pathological conditions of the brain, e. g. head injuries, brain tumors, vascular lesions, 
cerebral intoxications of endogenous or exogenous nature, and infectious processes, produces 
many serious neurological symptoms or signs and回neven be the causes of fatal sequelae. 
However, the inherent mechanism of cerebral edema or swelling has not been well clarified 
yet. 
Previous investigations95J studied by means of the electron microscope in this labora-
tory demonstrated some derangement of periodicity and disappearence of interperiodic l町ゼrs
of myelin sheath, and elective demyelination in the experimentally produced edematous 
brains of the田t. Also HoLTET42l43l disclosed a re¥・ersible chromatolytic changes78l of the 
nerve cel with enormous swelling of cytoplasm in the experimentally produced brain 
edema in rats. 
Of the two important kinds of glycolipids in the nervous tissue, cerebrosides9H 7J53l 59l 
are the important constituent of the myelin lipids9l together with sphingomyelin, cholesterol 
and phosphatidyl serine. They appear relativelv late either in phylogenetical69J85l or onto-
genetica!12J3oJ evolution of the brain, i. e. they 礼町 virtuallyabsent at birth and are deposited 
gradually in the course of myelination of the nerve fibers90l. ¥Vhile, gangliosides6l 5l 57J 
in the brain are found mainly in the grey matter"l55Jozi, especiallyア inthe microsomal 
fractions which contain fragments of cel membranes, particularly those of dendrites106J. 
They are present in the brains at birth90J. Different from many other lipids, gangliosides 
are acidic, acid-sensitive, non句dialysableand water-soluble. 
The aim of the present investigation was to study the met<1bolic changes of these two 
lipids during the course of cerebral swelling and to seek for some available information 
for the treatment of the cerebral traumatism. 
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EXPERIMENTAL PROCEDURE 
For the production of cerebral swelling in the experimental animals, right frontal lobe 
of the adult cats weighing 3.0 to 4.0 kg was compressed for 24 hours by the inflation of 
the rubber balloon which had been inserted epidurally. Cerebral compression was carried 
out under the E. E. G. control so as to standardize the degree of insultation. The opera-
tion was performed with ful aseptic precautions under ether anesthesia. Details of the 
technique of produceing cerebral swelling had been described previously'4l 45l 58'. 
主nimalswere sacrificed at immediately, 24 and 48 hours after evacuation of balloon 
content r引pecti\·el~.. The compressed portion of the brain was removed immediately after 
exsangumation and was frozen, using dry-ice. 入tthe same time, a corresponding portion 
of the side opposite to the compression was removed to serve as a control. Frozen material 
was stored at -20°C for the following examination. 
The brain was divided carefully into 山町 matter,subcortical white matter and brain-
stピmafter removal of pial vessels. 
Each sample was weighed on a torsion balance after removal of free water, by blott-
ing with a bit of filter paper (Toyo・roshiNo. 1). 
えnaliquot of tissue sample was homogenized for three minutes in a Potter-Elvehjem 
type of homogenizer with cold (4°C) 2 : 1 chloroform-methanol mixtures (v/v) to a 
final dilution 20 fold the volume of tissue sample. 
Extraction was carried out three times with solvent mixtures and then subjected to 
solvent partition as described by FoLCH, et al29>. The procedure used is outlined in 
Figure l. 
For the removal of non-lipids contamination and to separate gangliosides fromぽ re-
brosides, the crude lipid extract was washed with 0.2 volume of 0.37 per cent potassium 
chloride・ Themixture was allowed to separate into two phases by centrifugation at 2,400 
r. p. m. for twenty minutes. The lower phase was washed twice with 0.4 volume of 
pure solvent upper phase, a mixture of chloroform, methanol and 0.74 per cent potassium 
chloride in the proportions of 3 48 : 4 7by volume. 
Besides for these chemical assey a part of tissue aliquot was left for measurement of 
dry weight. 
DetermiJZation of cerebra占ides.
Cerebrosides were引 timatedby their galactose moiety which was released by hydrolysis 
in hydrochloric acid. 
An aliquot of lower phase which had been made to standard volume and contained 
10 mg of grey matter in wet weight or 2 mg of white matter in wet weight was eva-
porated to dryness under reduced pressure. 
After the samples were hydrolysedり in3 N hydrochloric acid for 45 minutes in a 
boiling water bath, fatty acids were removed by centrifugation and glycerol was removed 
by washing with ice-cold ethyl acetate according to EDMAN20>. 
Galactose was estimated by carfコazol reaction of DrscHE18l 19> with some modification 
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Figure 1. 
Determinatiυ1 of gangliosides. 
Gangliosides were estimated by their N-a.cetyl neuraminic acid moiety which was 
released by hydrolysis in aqueous sulfuric acid. 
The three upper phases obtained from above mentioned procedures (cf. Figure 1.) 
were combined and concentrated almost to dryness, then dialyzed for 24 hours against 
distilled water at 4°C in a 0.25 in. diameter Visking sack in cylindrical jars of approxi-
mately 10 I.capacity, with four changes of water, being agitated by a magnetic stirrer. 
After dialysis, the sacks were emptied and rinsed and the contents were made to a standard 
volume. An aliqot (0.4 ml.) of the dialyzed upper phase obtained from 50 mg of grey 
matter in wet weighL was hydrolysed in 0.1.:¥ sulfuric acid for one hour at 80°C in a 
water bath. Determinations of N-acetyl neuraminic acid content were carried out accord-
ing to ¥V ARREN’s thiobarbituric acid method46J 103J. Optical densities at 532 and 549 m;.1, 
were determined by a BECKMANN’s electrophotometric colorimeter. The formula ／.／，おfof 
N-acetyl neuraminic acid=0.09 OD5490一0.033OD5320 was used to correct for 2-deoxyribose 
contamination, though it was almost negligible. X aじピtylneuraminic acid from horse erv-
throcytes, obtained from Takeda Pharmaceutical Co., Ltd., was used as a standard. 
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Deter111ination of dr}' weights of tissue samples. 
For the pu叩oseof determining dry weights of tissue samples small flat bottomed 
vials measuring approximately 10 mm in length and 8 mm indiameter and weighing about 
500 mg were used as containers. The tissue samples of about 100 mg wet weight were 
dried for two and half hours at a temperature of I 05-110° C in an oven. Samples were 
weighed before and after drying. 
All analysis described here were done in duplicate, and experiments with difference 
in values between duplicate samples gr伺 terthan 8 per cent were discarded. 
Application of uridi11e derivat如何 forthe treatment of animals with cerebral trauma. 
Uridine derivatives, including uridine, UTP and UDP-glucose were given for the thera-
peutic purpose to the animals with cerebral traumatism produced by the epidural cerebral 
compression method which had been described above. Drugs were given in a dosis of 
60 mg (20 mg/kg body weight) intravenously through a poly-ethylene tube which had 
been inserted through the right external jugular vein previously. 
RESULTS 
Figures 2 and 3 and Table 1 give the concentration of cerebrosid白 inthe subcortical 
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hours periodes after evacuation of balloon content are 4.83士0.35and 5.10士1.04on the 
compressed side, 4.92士0.42and 5.28士0.82on the side opposite to the compression res-
pectively. No significant changes are found in these values when compared with those of 
normal brain or with those of the opposite弓idein each 
;.rs.or brain specimen. In the brain-stem, they are 3.07士
'i I . ι 0.71 and 3.69士0.61f町 O and 24 hours specimens 
! I :; －・＿ and again no significant shift from normal values is 
「α0ト唱L ・ ． 2』~ I永 i.___r noticed. For the grey matter, however, concentration 
; Iタ＼企／ I ・ ofcerebrosides in 0 and 24 hours specimens 川 1.07 。 E 司El 句・・ ±0.15 and 1.30士0.13 respect附 ly, and slight incre-
弐5.0ト
よー ＼ー _ . -・' ment of these values from normal specimens is noted. 
ol ニ ～ ・－.戸川 ＂－＜.••・RAL AC~附γ The concentration of gangliosides of grey matter 
NORMAL 0 24 48 
HRS AFTER E湖CUATION in normal and edematous brain are given in Figure 4 
OF B嶋LLOONCONTENTS and Table 2. Their amounts for normal speciemns 
Figure 4・ are9.28士1.84p mole只／gdry weight and are similar 
Table 2. .：＼川lllllト ofgangliosides in normal and to those reported by the others56> 60>. Those 
edematous四tbrain. (1 mnleト／日 dry values for 0, 24 and 48 hours specimens are 
!ht) Results a問 exoressedas mean 士S~E.:VL I 1'=0.05) ！＼~~伽 ofanir凶 6.81士O.99, 8.55士1.11and 8.85士2.07 日s-
examined are shown m問問th悶ses. pectively. Here is significant denea句 of 
Normal I the 9.28士1.84(20 ）
, cerebral activity as was expressed by E. E. 
0 hour 明 cimensi 6.81土0.9 （川 G. tracing and clinical symptoms w川 maximal-
Edematous ' 2-1hou四 specimensi 8.5士1.1l C 7) ly deteriorated. With restoration of cerebral 
j 48 hours、pecirnen、8.85士2.07l 6 ) 
activity, after removal of the content of the 
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Figure 5 shows the changes of weight 
of grev matter and white matter specimens 
during heating at a temperature of 105-110°〔
in an oven. The values are expressed by per 
－一← centof initial weight. It shows a decrement 
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Figure 5. 
curve of tissue weight which arri＼・り toa 
plateau within two hours both in the grey 
and the white matter. It is clear from the 
Table 3. Dry weight/wet weight per cent of gre1・ n】aterand white mater of normal and edematous 
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figure that two and a half hours are enough to dry up the specimen. Table 3 shows 
dry weight wet weight per cent of grey matter and suhcortical white matter of normal 
and compressed cat brains. .¥Jormal values for grey matter and white matter are 19.5士
1.1 and 31.6士2.1respectively. No significant changes are obtained from the table dur-
ing the course of epidural compression, when free water of tissue were eliminated by 
blotting with a bit of filter paper before determination. 
Uridine derivati＼＇刊 were given to the brain damaged animals intravenously for the 
therapeutic purpose. Figures 6 and 7 show restoration of cerebral acti¥'ity as was expressed 
in E. E. G. tracing after the administration of uridine, 60 mg (20 mg/kg boclv weight) 
intravenously for the dn川町 catswith the brain traumatism of the fairly constant degree. 
Before administration of the drug, E. E. G. displayed high voltaεe slow bursts (3-8 cps) 
in the bilateral leads, predominant on the compressed side. Three to five minuts after injec-
tion of the drug, high voltage slow waves began to disappear and nearly normal E. E. 
G. with alpha activity appeared after ten to fifteen minutes. These effects persisted for 
forty to fiftv minutes following the injection. The eff亡ctsof uridine were reproduceable 
and similar results were obtained with another thr肘 cats.
Administrations of UTP and UDP glucose wぞrealso tried to the brain traumatized 
animals in the dosis of 20 mg/kg body weight. These drugs were, however, les effective in 
restoring cerebral activity than uridine of the same dosis. Improvement of E. E. G. findings 
was also noticed in these cats but it persisted on!¥' for ten minutes or slightly longer. 
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As mentioned previously, cerebrosides (Figure 8) 
are one of the typical myelin lipids, composing lipo-
protein membrane structure of myelin63> 54l together 
with other lipids and proteins as w川 descrbedby 
FINE.叩121i2>2s> 24J 25J 26J 2n2 si and others32> a3J 64) '4l 8J 93) 
through their electron mien怖じけpie,biochemical and .¥ 
ray difraction studies. Further, considering the oh>-errn-
tions as presented by LusE63l and De RoBERT1s16l and 
Figure s 
others83l, that myelin sheath is constructed l〕yinvaginat-
ed limiting membrane proじessof oligodendroglia, metabolism of this tissuぞ shouldbe irト
timately related to the function of oligodendroglia. There have been presented number 
of investigations13l 14> 35l 35l 5> 57l 95l 9l concerning the morphological changes in oligodendro-
glial cells in the edematous subcortical white matter either by light or electron microscope 
which demonstrated some regressive changes of these ιモlsespecially in the late stage of 
pathological conditions. For this reason some changes had been expected in the metabo-
lism of this lipid in the edematous brain. Inspite of this expectation, however, in the present 
study, no remarkable changes were observed in the amounts of cerebroside只inthe edematous 
brain, both in the subcortical white matter and brain-stem. On the contr川 v,in l九TALLERIAN
degeneration, as was reported by JoHNSON48>49l and others66l57l, cerebroside失insciatic nerve 
myelin sheath had decreased, but it is a late phenomenon and may not he seen in the 
acute stage. SEITELBERGER91l 92l reported, in the demyelinating disease of the cerebrum, 
cerebrosides stil remained17l in the perivascular granular cells in the form of どれmular
lipids even in the last stage of the myelin sheath destruction. From these reasonヘwe
may conclude that cerebrosides are inert kinds of myelin lipid and les changeable at least 
in the acute stage of the brain damage. 
Here, there is some discrepancy about the cerebrosides metabolism in the只revmatter. 
As is mentioned before, cerebrosides are lipids of myelin nature and not found in the cel 
component. Major portion of cerebrosides in the gre；.ア matterof the normal brain deter-
mined here should be therefore considered to be of mvelin nature, which is inevitably 
mingled into this grossly separated cerebral composition. Inerぞmentof cerebrosides in the 
grey matter of the edematous brain will be discussed later with relation to gangliosides. 
Gangliosides (Figure 9) 5l 5l 57l are essentially the lipids of nピrwcells in the brain54l55l52>. 
Numerous informations could be obtained concerning the importance of this lipid in the 
cerebral activity70l 71> 72> 73> 101>. MclLWAIN70> 71l 12> 73> had reported the necessitv of this lipid 
or its relating compounds to retain or restore the electrical reactivity of the nゼn・ecel in 
vitro. WOLFE106> disclosed its specific localization in the microsomal fraction川 84)p川＼Jじularly
in the dendrite and he discussed on the similar localization of synaptic v明icl引 insubcellular 
fractionation as investigated by 羽TmTTAKER34l104>and others.15>79is1i82l89l 
From the results of this investigation, presenting decrement of the amounts of gan-
gliosides parallel to the cerebral deterioration indicated by E. E. G. and clinical c;rn1ptoms, 




















in vi丸町 and 2) it is possible that the decrement of this substance will be responsible in 
part for the deterioration of cerebral activity which was often observed in the case of 
cerebral edema. As we reported elswhere2l, activation of phospholipids turn-over by acetyl 
choline, of which mechanism is proposed to concern with the integrity of microsomal 
structure in the nerve cells as designated by HoK1N38>39>•0>•1l, was greatly depressed in the 
anoxic brain. Considering the local distribution of gangliosides in microsome of the nerve 
cel106> and their probable contribution to construct its membranous structure combined with 
proteins, interaction of伊 ngliosideswith phospholipids turn-over which was suspected to 
couple with the active transport of sodium ions through the cel membrane38> 39H0H1>, is 
只U店店estiveand this attracts profound interesting. 
It is known that gangliosides show relatively swift metabolic turn-over in the nerve tissue 
60> and are proposed to be catabolized by the gangliosidase S}•slc17159>, of which enzymatic 
activities are activated hy sequelae products of the degenerated nerve cel elements52> 102> as 
demonstrated by KOREY. Increase of じぞrebrosidesin the阿町 matterof the edematous brain 
may be well explained in this connection that increased cerebrosides may be the possible 
denatured product只ofthe gangliosides cleavage through this catabolic enzymatic system. 
On the other hand here stil remains another interpretation for this problem. It is 
not unlikely that the nucleoproteins released from the nucleus of the nerve cell during the 
course of cerebral edema due to the rupture of nuclear membrane have combined with 
gangliosides to form the compounds not extractable with chloroform-methanol mixtures. It 
is now known that gangliosides have strong affinity to basic proteins such as histone and 
protamine70> 71> 95> 105> and to make stable complexes which are insoluble to chloroform-
methanol mixtures3l 71> 73l 105> 106>. Migration of nucleoproteins through the nuclear membrane 
had also been reported in the regre只sivechanges of ganglion cells following the nerve section 
21>. In this connection, however, it is difficult to explain increase of cerebrosides in the 
grey matter of the edematous brain monisticallv. 
均・ntheticpathway of ιでrehrosid引 inthe brain had been well investigated by BURTON 
et al1°> as is outlined in Figure 10. 
UDP-galactose + N-acyl sphingo、刊
Figure 10. 山ntheticpathway of cerebroside、（Burton,R. M .Sodd, M. ¥. and Brad¥', R. 0., 
J. BiりlChぞ11•• z:i:. 1053 (1958). J 
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On the other hand, no reports on the biosynthesis of gangliosicles have yet been pub-
Jished. However, we may speculate on the synthetic pathway with two routes which are 
most probable at this time, as were designated by BURTON (Figure 11) 1' In these path-
ways UDP-glucose will 問 rveas the glucose donor to form gangliosides. UDP・-glucose 
in the brain will be synthesized through the pathays shown in Figure 12, in which lTTP 
is required to form UDP-glucose from glucose-1 phosphate51>68J;;i_ 
CH3(CH2112CH 
LTDP-glucose + HC-CH-CH-CHリー一子
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ぐ＝() 









Figure 11. Possible synthet1じ path＂川 崎ofgangliosides. (Burton, R. :'¥・!., inBrady, R. 0. and 
Tower, D. B. （巨ck),The Neurnchemistry off'iucle . tid田 andAmino Acick p. 51( 1959).) 
ATP UTP 
Glucose －一→ G-6-P一一→ G 1-P zコ UDP-glucose川 68)") 
1 DPN ATP UDP-G I↓ 
Galactose －一→ Gal-1-P ~ UDP-galactose 
Figure 12. 
UTP will be synthesized as follows. 
UMP十 ATP ＋＝コ UDP+ADP9•>
UDP+ATP ＋＝コ UTP+ADP•> 5>
or Pyruvate kinase 
UDP十Phosphoenolpyruvate ＋＝コUTP+ Pyruvate61> 76> 10> 
Existence of an enzyme capable of phosphorylating uridine to form UMP is proposed from 
GEIGER’s perfusion experiment31>, though it is not proved yet in vitro examination. 
From these conceptions we applied uridine derivatives, including uridine (Figure 13), 
UTP and UDP-glucose (Figure 14) for the therapeutic purpose to the animals with cerebral 
traumatism. Uridine was most effective in restorinεcerebral activitv, improving E. E.G. 
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findings, whereas UTP and UDP-glucose were les effective in the dosis of 20 mg/kg 






















Figure 13. Uridme 
:Vfotter of penetration of these substances across the Blood Brain Barrier and uptake into 
the neural cel in situ which are relating to the problem of active transport and pinocytosis 
will take part in this problem. Further investigation is neceぉaryto dissolve the problem. 
SUMMARY 
1. The concentration of cerebrosides and gangliosides was determined in the grey 
matter, sulコcorticalwhite matter and brain-stem of the normal and edematous cat brains at 
intervals of time 0, 24 and 48 hours after evacuation of epidural balloon content which 
had been compre州ingthe brain for 24 hours. 
2. Wet weight.1 dry weight retio was determined for grey and subcortical white 
matter of normal and edematous brains. However, no siεnificant difference in their values 
hetween normal and edematous brain was obtained if the free water of the specimen was 
1:・liminated by blottinεwith a bit of filter paper before the measurement. 
3. Cerebrosides, one of the typical myelin lipids changed litle in the subcortical white 
matter and brain-stem through the course of 48 hours. However, they slightly increased 
in the grey matter in the 0 and 24 hours periode specimens. 
4. Gangliosides, which virtually exist in the grey matter, particularly in the micro-
somal fraction which contains cel membranes and dendrites decreased significantly in O 
hour periode specimens and then returned to normal level within 48 hours, as cerebral 
~ Iじti v ity recovered. 
5. Uridine derivatives, including uridine, UTP and UDP-glucose which are indispen-
sable for the biosynthesis of gangliosides were adminstered intravenously to the animals 
with cerebral traumatism for the therapeutic purpose. Among above three, uridine was 
most efective in restoring the cerebral activity as was evidenced by E. E. G. findings. 
6. Results were discussed with reference to the morphological changes of neural cels 
in the edematous brain, tissue reactivity, gangliosidase S少ste例， migrationof nucleoproteins 
and also to the problem of penetration of nucleotides through Blood Brain Barrier. 
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与的変fじp 組織興奮性の問題， gangliosidase system 
及び核蛋白遊出の問題並びに nucleotidesの脳血液関門
通過の問題等に関述して検討論議した．
